Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Heartware International Inc (NASDAQ: HTWR) acted responsibly on behalf of investors’ profitability in the planned $1.1 billion sale to Medtronic plc (NYSE: MDT).

On June 27, 2016, Heartware International Inc (NASDAQ: HTWR) and Medtronic plc (NYSE: MDT) announced that they had entered into a merger agreement. Under the terms of the merger agreement, Medtronic will offer Heartware shareholders $58.00 per share in cash for all outstanding shares.    

Based in Framingham, Massachusetts, Heartware International Inc develops, manufactures, and markets miniaturized implantable heart pumps or ventricular assist devices (VAD) for the treatment of advanced heart failure.

The investigation is looking to uncover whether Heartware International Inc was undervalued at the cost of the shareholders considering one analyst’s opinion of their stock is valued at $60.00 per share.

If you purchased Heartware International Inc (NASDAQ: HTWR) prior to June 27, 2016, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185